Alzheimer’s disease (AD) is the most common form of dementia, afflicting more than 30 million people worldwide. Currently, there is no cure or way to prevent this devastating disease.
Via Krishan Maggon
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
Krishan Maggon 's curator insight,
September 20, 2014 4:47 PM
open access Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab Hadar Feinberg2, José W Saldanha5, Linnea Diep1, Amita Goel1, Angela Widom3,Geertruida M Veldman6, William I Weis2, Dale Schenk4 and Guriqbal S Basi1* *Corresponding author: Guriqbal S Basi gur1balbasi@gmail.com Author Affiliations 1Elan Pharmaceuticals, Inc. 300 Technology Sq., Cambridge, MA 02139, USA 2Departments of Structural Biology and of Molecular & Cellular Physiology, 299 Campus Drive, Stanford University School of Medicine, Stanford, CA 94305, USA 3Pfizer, Cambridge, MA, USA 4Prothena Biosciences, Inc., 650 Gateway Blvd., San Francisco, CA 94080, USA 5National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK 6Abbvie Bioresearch Center, Worcester, MA, USA For all author emails, please log on. Alzheimer's Research & Therapy 2014, 6:31 doi:10.1186/alzrt261 |
Review
Immunotherapy for Alzheimer’s disease: hoops and hurdlesCynthia A Lemere
Correspondence: Cynthia A Lemere clemere@partners.org
Author Affiliations
Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, NRB 636F, 77 Avenue Louis Pasteur, Boston 02115, MA, USA
Molecular Neurodegeneration 2013, 8:36 doi:10.1186/1750-1326-8-36
The electronic version of this article is the complete one and can be found online at:http://www.molecularneurodegeneration.com/content/8/1/36
Received:3 July 2013Accepted:23 September 2013Published:22 October 2013
© 2013 Lemere; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.